NRG-GY020

Randomized Phase III Trial of Radiation +/- MK-3475 (Pembrolizumab) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (DMMR) Endometrioid Endometrial Cancer

For more information about this clinical trial, click here

Schema & Eligibility NRG-GY020

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Mercy Hospital, St. Louis, MO

Ask your physician about participating in this clinical trial or call us.